Schonfeld Strategic Advisors LLC - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 30 filers reported holding APTEVO THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$47,124
-77.7%
142,800
-1.2%
0.00%
-100.0%
Q2 2023$211,116
-27.9%
144,600
+0.6%
0.00%
-33.3%
Q1 2023$292,633
-11.2%
143,800
+1.2%
0.00%0.0%
Q4 2022$329,672
-26.2%
142,100
-3.3%
0.00%
-25.0%
Q3 2022$447,000
-14.7%
146,900
+0.4%
0.00%
-20.0%
Q2 2022$524,000
-39.7%
146,300
-1.1%
0.01%
-37.5%
Q1 2022$869,000
-29.5%
148,000
-5.6%
0.01%
-27.3%
Q4 2021$1,233,000
+316.6%
156,700
+1515.5%
0.01%
+175.0%
Q1 2021$296,000
-27.3%
9,700
-12.6%
0.00%
-20.0%
Q4 2020$407,00011,1000.01%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$39,477,0007.86%
RTW INVESTMENTS, LP 281,402$6,312,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 187,995$4,217,0000.09%
Anson Funds Management LP 35,587$798,0000.08%
Alyeska Investment Group, L.P. 139,172$3,122,0000.04%
Dynamic Technology Lab Private Ltd 14,022$315,0000.03%
JBF Capital, Inc. 3,907$88,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 15,350$344,0000.01%
Renaissance Technologies 159,923$3,587,0000.00%
QS Investors, LLC 15,650$352,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders